GLP-1 receptors are widely expressed in the brain and spinal cord, and studies have shown that the long-acting GLP-1 receptor agonist exendin-4 (Ex-4) has neuroprotective effects in various animal models of neurodegenerative diseases, including stroke, Parkinson’s disease, and Alzheimer’s disease. This evidence concerns the gene GLP1R and stroke disorder.